Home Page
Advancing Cardiac Ablation
    AblaCor Medical Corporation is an early stage medical device company that is dedicated to the development of revolutionary, minimally invasive products that will transform catheter ablation into a first-line treatment for patients with atrial fibrillation (AFib). Formerly known as Automated Medical Instruments, the company is developing the patent pending CircumBlator™ PVI Ablation System. Key opinion leaders from prominent institutions have described our technology as game-changing. The Company is led by experienced medical device executives and entrepreneurs. Headquartered in Needham, MA, AblaCor is privately held.

    Atrial fibrillation presents a significant public health problem for over 5 million Americans and over 30 million globally. AFib is a progressive disease that destroys quality of life, causes 15-25% of strokes and is associated with billions of dollars of cost and lost productivity.

    Contact Martin J. Sklar, CEO and Founder of AblaCor Medical Corporation by email at msklar@ablacor.com or by phone at 781-248-6841 for more information.

Website Builder